[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-354062-105":59,"doc-detail-354062-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","ai-based-triage-and-decision-support-in-mammography-and-digital-tomosynthesis-for-breast-cancer-screening-a-paired-noninferiority-trial","AI-based triage and decision support in mammography and digital tomosynthesis for breast cancer screening - a paired, noninferiority trial","","Prospective, paired, noninferiority clinical trial assessing whether AI can safely reduce radiologist workload in breast cancer screening by excluding low-risk mammography exams from radiologist reading. Between March 2022 and January 2024, 31,301 women underwent routine mammograms. Two parallel strategies compared standard double-blind reading with partially autonomous AI-supported screening. Primary outcomes were radiologist workload, cancer detection rate and recall rate. AI reduced workload by 63.6% and increased cancer detection from 6.3 to 7.3 per 1,000, but recall rate was 14.8% higher. Modality subanalyses showed similar workload reduction across digital mammography and DBT, with stable detection and differing recall changes.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/ai-based-triage-and-decision-support-in-mammography-and-digital-tomosynthesis-for-breast-cancer-screening-a-paired-noninferiority-trial/354062/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/ai-based-triage-and-decision-support-in-mammography-and-digital-tomosynthesis-for-breast-cancer-screening-a-paired-noninferiority-trial/354062.png","ImageObject",300,407,{"name":92,"@type":93},"Sarah ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-09","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":56},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How does the AI-supported workflow reduce radiologist workload in this trial?","Question",{"text":112,"@type":113},"Cases classified by AI as low risk were treated as normal, while the remaining cases underwent double reading with AI support.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What were the primary outcomes measured?",{"text":117,"@type":113},"Radiologist workload, cancer detection rate, and recall rate were the primary outcomes.",{"name":119,"@type":110,"acceptedAnswer":120},"Did the AI strategy maintain safety compared with standard double-blind reading?",{"text":121,"@type":113},"The AI strategy reduced workload and increased cancer detection, but recall rate was not noninferior and was higher under the AI approach.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},354062,1790529757,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":56,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962085320529,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","nature medicine  \nArticle [https://doi.org/10.1038/s41591-026-04277-x](https://doi.org/10.1038/s41591-026-04277-x)  \nAI-based triage and decision support in mammography and digital tomosynthesis for breast cancer screening: a paired, noninferiority trial  \nReceived: 12 January 2025  \nAccepted: 4 February 2026  \n\n| Published online: 19 March 2026 |\n| --- |\n|  Check for updates |\n\nEsperanza Elías-Cabot  1,2,3 , Sara Romero-Martín  1,2,3, José Luis Raya-Povedano  1,2,3, Alejandro Rodríguez-Ruiz4 & Marina Álvarez-Benito 1,2,3  \nArtificial intelligence (AI) systems have been demonstrated to improve the accuracy of screening mammograms. Here this prospective, paired, noninferiority clinical trial evaluated whether AI could safely reduce workload by excluding low-risk exams from radiologist reading. Between March 2022 and January 2024, 31,301 women were included in the trial and underwent routine mammograms. Two reading strategies were applied in parallel: standard double-blind reading and partially autonomous  \nAI-supported screening, where cases classified by AI as low risk were assessed as normal and the rest were double read with AI support. The primary outcomes were radiologist workload, cancer detection rate and recall rate. In the AI strategy, radiologist workload was 63.6% lower; the cancer detection rate was 15.2% higher (95% confidence interval 6.6%, 24.4%), increasing from 6.3 of 1,000 to 7.3 of 1,000, P \u003C 0.001; and the recall rate was not noninferior and was 14.8% higher (95% confidence interval 9.0%, 20.6%). Subanalyses by modality highlighted a similar workload reduction in digital mammography (−62.1%) and digital breast tomosynthesis (−65.5%). However, in digital mammography, the cancer detection rate increased by 1.6 of 1,000 and the recall rate by 1.3%, while both remained stable in digital breast tomosynthesis. These results demonstrate the feasibility of a partially automated AI workflow in breast cancer screening, avoiding human reading [of studies classified as low risk. ClinicalTrials.gov:](of studies classified as low risk. ClinicalTrials.gov: NCT04849776)[ NCT04849776](of studies classified as low risk. ClinicalTrials.gov: NCT04849776).  \nBreast cancer screening programs with digital mammography (DM) have been established for decades, with proven benefits in reducing breast cancer-related mortality1. Still, screening programs face clinical challenges in terms of both missed cancersand false positive recalls2. These can be improved by the use of digital breast tomosynthesis (DBT) and/or double reading, but atthe cost of an ever-increasing reading workload3. In light of population aging, recommendations for starting screening at younger ages and the increasing shortage of qualified radiologists in some areas, alternative approaches using  \nartificial intelligence (AI) have been proposed to maintain or even improve screening quality without increasing radiologists’workload4.  \nOver the last few years, several retrospective studies have shown that radiologists improved their cancer detection accuracy when using anAI system as concurrent reading support5–8. Furthermore, AI systems implemented as a stand-alone solution have been found to achieve human-like performance in simulated retrospective studies9–12, classifying exams according to cancer probability and resulting in simulations of AI-based breast cancer strategies that suggested improved  \nA full list of affiliations appears at the end of the paper. [e-mail:](e-mail: eeliascabot@gmail.com)[ eeliascabot@gmail.com](e-mail: eeliascabot@gmail.com)  \nFig. 1 | Study profile. Flowchart describing the inclusion of the study population, the women excluded and the different reasons for exclusion.  \n\n| clinical outcomes4,13–17. Several prospective studies have been designed | opportunity to participate on a voluntary basis. A total of 31,856 |\n| --- | --- |\n| to overcome the limitations of retrospective studies and to address and quantify the real-life impact of AI in ","cbCaituyzdySK6fm","https://ap.wps.com/l/cbCaituyzdySK6fm","pdf",5927167,27,"English","# Study overview\n## Trial design and strategies\n## Outcomes and results\n## Modality subanalyses","[{\"question\":\"How does the AI-supported workflow reduce radiologist workload in this trial?\",\"answer\":\"Cases classified by AI as low risk were treated as normal, while the remaining cases underwent double reading with AI support.\"},{\"question\":\"What were the primary outcomes measured?\",\"answer\":\"Radiologist workload, cancer detection rate, and recall rate were the primary outcomes.\"},{\"question\":\"Did the AI strategy maintain safety compared with standard double-blind reading?\",\"answer\":\"The AI strategy reduced workload and increased cancer detection, but recall rate was not noninferior and was higher under the AI approach.\"}]","AI-based triage and decision support in mammography and digital tomosynthesis for breast cancer screening - a paired, noninferiority trial | PDF",1790108655,68,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/07c40c2118ac6541616b39ae326cdeb0.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/04d4a2fbd88e55755953274bda598af0.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/504c788b6371ade267da1de96833736b.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f3940c153590bd3db64a8c7da4b6043f.webp",980,1301]